These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 31120857)

  • 1. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia.
    Ito A; Ishida T; Tachibana H; Arita M; Yamazaki A; Washio Y
    Clin Chem Lab Med; 2019 Sep; 57(10):1632-1637. PubMed ID: 31120857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
    Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
    Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.
    Krüger S; Ewig S; Papassotiriou J; Kunde J; Marre R; von Baum H; Suttor N; Welte T;
    Respir Res; 2009 Jul; 10(1):65. PubMed ID: 19594893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia.
    Guo S; Mao X; Liang M
    Respir Res; 2018 Oct; 19(1):193. PubMed ID: 30285748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.
    España PP; Capelastegui A; Bilbao A; Diez R; Izquierdo F; Lopez de Goicoetxea MJ; Gamazo J; Medel F; Salgado J; Gorostiaga I; Quintana JM;
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3397-405. PubMed ID: 23010902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
    Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
    Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
    Wang Y; Zhang S; Li L; Xie J
    Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ.
    Krüger S; Ewig S; Kunde J; Hartmann O; Marre R; Suttorp N; Welte T;
    Clin Chim Acta; 2010 Dec; 411(23-24):1929-34. PubMed ID: 20699094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
    Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
    Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high C-reactive protein/procalcitonin ratio predicts Mycoplasma pneumoniae infection.
    Neeser OL; Vukajlovic T; Felder L; Haubitz S; Hammerer-Lercher A; Ottiger C; Mueller B; Schuetz P; Fux CA
    Clin Chem Lab Med; 2019 Sep; 57(10):1638-1646. PubMed ID: 31128571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Procalcitonin, White Blood Cell and Hypersensitive C-reactive Protein Combined with Age Established a New Prediction Model in Predicting ICU Admission in Adult Community-Acquired Pneumonia (CAP) Patients.
    Li WQ; Chen Y; Liu TJ; Xie BQ; Fu AS; Li LQ; Ge YL; Min P; Lu Y; Liu Y; Sun Y; Hou LL; Jing Q; Zhang HF; Zhang JB
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage.
    Sun Y; Jiang L; Shao X
    Int Urol Nephrol; 2017 Dec; 49(12):2205-2216. PubMed ID: 28956241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin and C-reactive protein perform better than the neutrophil/lymphocyte count ratio in evaluating hospital acquired pneumonia.
    Zheng N; Zhu D; Han Y
    BMC Pulm Med; 2020 Jun; 20(1):166. PubMed ID: 32527243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
    BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
    Agnello L; Bellia C; Di Gangi M; Lo Sasso B; Calvaruso L; Bivona G; Scazzone C; Dones P; Ciaccio M
    Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of blood parameters for community-acquired pneumonia.
    Huang Y; Liu A; Liang L; Jiang J; Luo H; Deng W; Lin G; Wu M; Li T; Jiang Y
    Int Immunopharmacol; 2018 Nov; 64():10-15. PubMed ID: 30144639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.